Form D · Biotechnology

TYROGENEX, INC.

Palm Beach Gardens, FL · CIK 0001471413

Offering snapshot reported Feb 26, 2016 · SEC filing

Reported sold
$544K
Offering amount: $12M
Investors reported
18
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Feb 11, 2016
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 26, 2016Initial$543,952No comparison18SEC filing
Apr 18, 2014Initial$8,218,436No comparison40SEC filing
Apr 10, 2014Initial$3,294,909No comparison38SEC filing
Apr 5, 2012Initial$1,590,000No comparison6SEC filing
Dec 14, 2011Initial$970,000No comparison6SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$24.5K (estimated)
Finders' fees
$0
Form D file number
021-258194

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Cuttone & Co., Inc.33038TAG Healthcare Advisors, LLC

Source: Form D, filed Feb 26, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Todd Brady Director
Cheryl Calhoun Director
Adam Goodfriend Director
John Irwin Iii Director
Chris Liang Director, Executive
Dennis L. Palmgren Director
Vinzenz Ploerer Director
Sheridan Snyder Director
Joseph Straight Executive
Teri A. Swift Executive
Michael Webb Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
11780 U.S. Hwy One, Suite 202
Palm Beach Gardens, FL, 33408